High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation

Oncogene

Volumn 15, Issue 11, 1997, Pages 1263-1273

  Bounacer, A ^a   Wicker, R ^a   Caillou, B ^b   Cailleux, A F ^a,b   Sarasin, A ^a   Schlumberger, M ^b   Suarez H G ^a  

^a CNRS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Activating rearrangements; Radiation associated tumors; ret protooncogene; RET PTC oncogene

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BELARUS; CHERNOBYL ACCIDENT; CHILD; CHIMERA; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE RET; PREVALENCE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIOACTIVE WASTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

EID: 0030929178     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200206     Document Type: Article

References (56)

1. Bongarzone I, Pierotti M, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G and Della-Porta G. (1989). Oncogene, 4, 1457-1462.
2. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della-Porta G and Pierotti MA. (1993). Mol. Cell. Biol., 13, 358-366.
3. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M. Mondellini P, Pilotti S, Fusco A, Della-Porta G and Pierotti MA. (1994). Cancer Research, 54, 2979-2985.
4. Challeton C, Bounacer A, Du Villard JA, Caillou B, De Vathaire F, Monier R, Schlumberger M and Suárez HG. (1995). Oncogene, 11, 601-603.
5. Conard RA, Dobyns BM and Sutow WW. (1970). JAMA, 214, 316-324.
6. Delvincourt C, Patey M, Flament JB, Suarez HG, Larbre H, Jardillier JC and Delisle MJ. (1996). Clinical Biochemistry, 29, 267-271.
7. Diallo I, Lamon A, Shamsaldin A, Grimaud E, De Vathaire F and Chavaudra J. (1996). Radioth. and Oncol., 38, 269-271.
8. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore T, Howe JR, Moley JF, Goodfellow P and Wells SA. (1993). Hum. Mol. Genet., 2, 851-856.
9. Duffy BJJ and Fitzgerald PJ. (1950). J. Clin. Endocrinol. Metab., 10, 1296-1308.
10. Durbec P, Marco-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Sariola H and Pachnis V. (1996). Nature, 381, 789-793.
11. Eng C, Smith DP, Mulligan LM, MA N, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A and Ponder BAJ. (1994). Hum. Mol. Genet., 3, 237-241.
12. Fogelfeld L, Bauer TK, Schneider AB, Swartz JE and Zitman R. (1996). J. Clin. Endocrinol. Metab., 81, 3039-3044.
13. Fraker DL. (1995). Endocrine Surgery, 75, 365-375.
14. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F and Pierotti MA. (1995). Cancer Research, 55, 5617-5620.
15. Fugazzola L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV and Bongarzone I. (1996). Oncogene, 13, 1093-1097.
16. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della-Porta G, Fusco A and Vecchio G. (1990). Cell, 60, 557-563.
17. Hedinger C, Williams ED and Sobin LH. (1989). Cancer, 63, 908-911.
18. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T and Nagao M. (1991). Oncogene, 6, 1667-1672.
19. Ito T, Seyama T, Iwamoto KS, Hayashi M, Mizuno T, Tsuyama N, Dohi K, Nakamura N and Akiyama M. (1993). Cancer Res., 53, 2940-2943.
20. Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K and Akiyama M. (1994). The Lancet, 344, 259.
21. Jackson DP, Quirke P, Lewis F, Boylston AW, Sloan JM, Robertson D and Taylor GR. (1989). The Lancet, 1, 1391.
22. Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu IM and Mazzaferri EL. (1992). Oncogene, 7, 1331-1337.
23. Kazakov VK, Demidchik EP and Astakhova LN. (1992). Nature, 395, 21.
24. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. (1995). Oncogene, 11, 2459-2467.
25. Lemoine NR, Mayall ES, Wyllie FS, Farr CJ, Hughes D, Padura RA, Thurston V, Williams ED and Wynford-Thomas D. (1988). Cancer Res., 48, 4459-4463.
26. Michelin S, Daya-Grosjean L, Sureau F, Saïd S, Sarasin A and Suárez HG. (1993). Oncogene, 8, 1983-1991.
27. Mulligan LM, Kwok JB, Healey CS, Elsdon M, Eng C, Gardner E, Love D, Mole S, Moore J, Papi L, Ponder M, Telenius H, Tunnacliffe A and Ponder B. (1993). Nature, 363, 458-460.
28. Nikiforov YE, Nikiforova MN, Gnepp DR and Fagin JA. (1996). Oncogene, 13, 687-693.
29. Pachnis V, Mankoo B and Constantini F. (1993). Development, 119, 1005-1017.
30. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. (1993). Nature, 365, 649-651.
31. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA and Boice JD. (1995). Radiat. Res., 141, 259-277.
32. Russo D, Arturi F, Wicker R, Chazenbalk M, Schlumberger M, Du Villard JA, Caillou B, Monier R, Rapoport B, Filetti S and Suárez HG. (1995). J. Clin. Endocrinol. Metab., 80, 1347-1351.
33. Saïd S, Schlumberger M and Suárez HG. (1994). J. Endocril. Invest., 17, 371-379.
34. Sanger F, Nicklen S and Coulson AR. (1977). Proc. Natl. Acad. Sci. USA, 82, 488-492.
35. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della-Porta G, Berger N, Peix J, Paulin C, Fabien N, Vecchio G, Jenkins RB and Fusco A. (1992). J. Clin. Invest., 89, 1517-1522.
36. Santoro M, Dathan N, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G and Fusco A. (1994). Oncogene, 9, 509-516.
37. Schuchardt A, D'Agati V, Larsson BL, Costantini F and Pachnis V. (1994). Nature, 367, 380-383.
38. Shore RE, Woodard E, Hildreth N, Dvoresky P, Hempelmann L and Pasternack B. (1985). J. Natl. Cancer Inst., 74, 1177-1184.
39. Shore RE. (1992). Radiation Res., 131, 98-111.
40. Shore RE, Hildreth N, Dvorestsky P, Andersen E, Moseson M and Pasternack B. (1993). Amer. J. Epidemiol., 137, 1068-1080.
41. Smanik PA, Furminger TL, Mazzaferri EL and Jhiang SM. (1995). Human Molecular Genetics, 4, 2313-2318.
42. Stary A and Sarasin A. (1992). Nucleic Acids Res., 20, 4269-4274.
43. Stoppa-Lyonnet D, Carter PE, Meo T and Tosi M. (1990). Proc. Natl. Acad. Sci. USA, 87, 1551-1555.
44. Suárez HG, Du Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R. (1990). Oncogene, 5, 565-570.
45. Suárez HG, Du Villard JA, Caillou B, Schlumberger M, Parmentier C and Monier R. (1991). Oncogene, 6, 677-679.
46. Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S and Asa SL. (1996). J. Clin. Endocrin. and Metab., 81, 3360-3365.
47. Takahashi M, Ritz J and Cooper GM. (1985). Cell, 42, 581-588.
48. Takahashi M and Cooper GM. (1987). Mol. Cel. Biol., 7, 1378-1385.
49. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H and Hiai H. (1988). Oncogene, 3, 571-578.
50. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Gruesco E, Pachnis V, Arumäe U, Sariola H, Saarma M and Ibanez CF. (1996). Nature, 381, 785-789.
51. Vigliettoj G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A. (1995). Oncogene, 11, 1207-1210.
52. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M and Takahashi M. (1992). Jpn. J. Cancer Res., 83, 671-675.
53. Wood JW, Tamagaki M, Sato T, Sheldon W, Archer PG, Hamilton HB and Johnson KG. (1969). Am. J. Epidemiol., 89, 4-14.
54. Wright P, Williams ED, Lemoine NR and Wynford-Thomas D. (1991). Oncogene, 6, 471-473.
55. Wynford-Thomas D. (1993). Critical Rev. in Oncog., 4, 1-23.
56. Zou M, Shi Y and Farid NR. (1994). Cancer, 73, 176-180.